CD274 and head and neck squamous cell carcinoma: Additionally, recurrent tumors exhibited significantly higher positivity rates for immune PD‐L1 in early recurrence, indicating that the early recurrence of HNSCC is mediated through immune regulation by upregulated PD‐L1, which would be an ideal target for the PD‐1/PD‐L1 inhibitors.